WHO

Virtual Event: 1st Global Forum On Access To Safe Blood Products For Patients In Need Of Regular Transfusion – 5 November 2021
Blood

Virtual Event: 1st Global Forum On Access To Safe Blood Products For Patients In Need Of Regular Transfusion – 5 November 2021

Expected Outcomes An understanding of the strategic vision and goals for blood safety and the protection of the blood supply, especially in low-income settings; A better understanding of the key…
COMING UP: 1st Global Forum On Access To Safe Blood Products For Patients In Need Of Regular Transfusion – 5 November 2021
Νέα

COMING UP: 1st Global Forum On Access To Safe Blood Products For Patients In Need Of Regular Transfusion – 5 November 2021

Expected Outcomes An understanding of the strategic vision and goals for blood safety and the protection of the blood supply, especially in low-income settings; A better understanding of the key…
WHO SEARO Publishes Desk Review of Haemoglobinopathies in the South-East Asia Region
Νέα

WHO SEARO Publishes Desk Review of Haemoglobinopathies in the South-East Asia Region

In an effort to understand the prevalence of thalassaemic syndromes and the existent blood supply system available within each country of the South-East Asia Region, the WHO Regional Office for…
TIF Takes Active Part In The 71st Session of the WHO Regional Committee for Europe
Νέα

TIF Takes Active Part In The 71st Session of the WHO Regional Committee for Europe

TIF has participated in the 71st session of the WHO Regional Committee for Europe between 13–15 September 2021, which gathered six hundred high-level delegates, including over 30 Health Ministers from…
CDC, FDA Authorize Third Dose Of COVID-19 Vaccines For The Immunocompromised In The US
Κλινικά Νέα

CDC, FDA Authorize Third Dose Of COVID-19 Vaccines For The Immunocompromised In The US

The U.S. Food and Drug Administration (FDA) and the U.S. Centers for Disease Control and Prevention (CDC)  have both recommended on August 16 that certain immunocompromised people receive a third…
Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization
Κλινικά Νέα

Chinese Sinovac COVID-19 Vaccine Approved By World Health Organization

The World Health Organization (WHO) announced yesterday that it has approved a COVID-19 vaccine made by Sinovac Biotech (SVA.O) for emergency use listing, paving the way for a second Chinese shot…
WHO Director General Dr Tedros Adhanom to address TIF’s Global Thalassaemia Review High-level Event
Νέα

WHO Director General Dr Tedros Adhanom to address TIF’s Global Thalassaemia Review High-level Event

In celebration of the International Thalassaemia Day 2021,  the Thalassaemia International Federation (TIF) proudly presents a High-level Event for the Official Premiere of the Federation’s Global Thalassaemia Review, to take…
WHO Maintains Official Relations With TIF For 2021-2024
Νέα

WHO Maintains Official Relations With TIF For 2021-2024

We are very proud to inform you that TIF remains in official relations with the World Health Organization (WHO) for 2021-2024 The extension of ΤIF’s official relations with WHO was…
Coronavirus Pandemic: How Close Are We to a Vaccine?
Κλινικά Νέα

Coronavirus Pandemic: How Close Are We to a Vaccine?

Researchers around the world are racing to develop a vaccine against Covid-19, with more than 140 candidate vaccines now tracked by the World Health Organization (WHO). Vaccines normally require years of testing…
TIF’s Global Call for Solidarity & Cooperation in support of WHO
Νέα

TIF’s Global Call for Solidarity & Cooperation in support of WHO

  TIF expresses major concerns over the announcement of the United States to suspend financial support for the World Health Organisation (WHO) until completion of a review of the organisation’s activities related…
Back to top button